- Home
- EVO vs ARR Comparison
EVO vs ARR Comparison
Compare EVO & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- ARR
- Stock Information
- Founded
- EVO 1993
- ARR 2008
- Country
- EVO Germany
- ARR United States
- Employees
- EVO N/A
- ARR N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- ARR Real Estate Investment Trusts
- Sector
- EVO Health Care
- ARR Real Estate
- Exchange
- EVO Nasdaq
- ARR Nasdaq
- Market Cap
- EVO 1.5B
- ARR 1.3B
- IPO Year
- EVO 2021
- ARR N/A
- Fundamental
- Price
- EVO $4.34
- ARR $16.85
- Analyst Decision
- EVO Buy
- ARR Hold
- Analyst Count
- EVO 2
- ARR 5
- Target Price
- EVO $5.90
- ARR $21.00
- AVG Volume (30 Days)
- EVO 120.0K
- ARR 2.5M
- Earning Date
- EVO 08-13-2025
- ARR 07-23-2025
- Dividend Yield
- EVO N/A
- ARR 17.09%
- EPS Growth
- EVO N/A
- ARR N/A
- EPS
- EVO N/A
- ARR N/A
- Revenue
- EVO $851,944,444.00
- ARR $44,778,000.00
- Revenue This Year
- EVO $10.08
- ARR $532.77
- Revenue Next Year
- EVO $10.99
- ARR $15.62
- P/E Ratio
- EVO N/A
- ARR N/A
- Revenue Growth
- EVO 1.50
- ARR 41.14
- 52 Week Low
- EVO $2.84
- ARR $13.18
- 52 Week High
- EVO $5.64
- ARR $21.93
- Technical
- Relative Strength Index (RSI)
- EVO 57.99
- ARR 58.22
- Support Level
- EVO $4.15
- ARR $16.43
- Resistance Level
- EVO $4.33
- ARR $16.73
- Average True Range (ATR)
- EVO 0.11
- ARR 0.26
- MACD
- EVO 0.02
- ARR 0.02
- Stochastic Oscillator
- EVO 85.92
- ARR 90.70
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.